Salt Composition

You Searched

Cipmolnu 200 Capsule 40 capsules

Cipla Ltd.

Bottle of 40 capsules

₹2,000

₹50 / Unit

All Our Medicines are

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

Uses of Cipmolnu 200 Capsule 40 capsules

Treatment of Mild to moderate Coronavirus disease (COVID-19)

More About Cipmolnu 200 Capsule 40 capsules

Benefits

Side Effects

How to use

How it works

What if I forget to take it?

Manufacturer Address

Benefits

Treatment of Mild to moderate Coronavirus disease (COVID-19)

In Treatment of Mild to moderate Coronavirus disease (COVID-19)Cipmolnu 200 Capsule helps manage mild to moderate Covid-19 symptoms in those individuals who are at a high risk of developing severe Covid-19 disease and do not need oxygen administration. This medicine may help you recover from the infection if diagnosed early before hospitalization. If you think you have come in contact with a person who has been infected with Covid-19, or if you feel any of these symptoms, consult your doctor immediately.

Side Effects

The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.

How to use

Follow your doctor's guidance regarding the dose and duration of this medication. Cipmolnu 200 Capsule can be taken it with or without food, although it's advisable to take it consistently at the same time.

How it works

Cipmolnu 200 Capsule is an antiviral medicine. It works by inhibiting the SARS-Co V-2 virus from replicating. This stops the virus from producing new copies and hence decreases the viral load in the body.

Alcohol

Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Cipmolnu 200 Capsule . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.

Pregnancy

Seek medical advice from your doctor: Cipmolnu 200 Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.

Breast feeding

Not Safe: Cipmolnu 200 Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

Seek medical advice from your doctor: It is not known whether Cipmolnu 200 Capsule alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

Safe when prescribed by an expert: Cipmolnu 200 Capsule is safe to use in patients with kidney disease. No dose adjustment of Cipmolnu 200 Capsule is recommended.

Liver

Safe when prescribed by an expert: Cipmolnu 200 Capsule is safe to use in patients with liver disease. No dose adjustment of Cipmolnu 200 Capsule is recommended.

What if I forget to take it?

If a dose of Cipmolnu 200 Capsule is missed, it's advisable to consult your doctor.

Manufacturer Address

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Frequently asked questions

Who is at a high risk of developing severe COVID-19?

High-risk individuals include those over 60, obese individuals, and those with comorbid conditions like high blood pressure, diabetes, asthma, or weakened immunity.

Who should not take Cipmolnu 200 Capsule 40 capsules?

Cipmolnu 200 Capsule 40 capsules should not be used to prevent COVID-19 or treat hospitalized patients, as clinical trials show no benefit for those with severe infections.

Can Cipmolnu 200 Capsule 40 capsules be given to children?

Cipmolnu 200 Capsule 40 capsules is not approved for children or patients under 18, as it may affect bone and cartilage growth.

What is the advantage of using Cipmolnu 200 Capsule 40 capsules?

Cipmolnu 200 Capsule 40 capsules offers better patient compliance than some COVID-19 treatments, as it is an oral medication that can be taken at home.

Are there any serious risks of taking Cipmolnu 200 Capsule 40 capsules?

Yes, Cipmolnu 200 Capsule 40 capsules can cause serious risks, including birth defects in pregnant women and damage to bone and cartilage growth. It should only be used if prescribed by a doctor.

Is taking Cipmolnu 200 Capsule 40 capsules better than getting vaccinated?

No, Cipmolnu 200 Capsule 40 capsules is not a substitute for vaccination. Vaccination prevents COVID-19, while Cipmolnu 200 Capsule 40 capsules treats an existing infection diagnosed early.

Content Written By

Shubham Kumar Singh

B pharmacy

3 Years of Experience

Content Reviewed By

Dr. Jay Faldu

MBBS

7 Years of Experience

Checkout Editorial Policy

References

Molnupiravir (05 Jan. 2022)

U.S. Food and Drug Administration: Center for Drug Evaluation and Research FDA Briefing Document, Antimicrobial Drugs Advisory Committee Meeting, November 30, 2021 (05 Jan. 2022)

Cipla receives Emergency Use Authorisation (EUA) to launch oral anti-viral drug Cipmolnu®(Molnupiravir 200mg) in India for treatment of adult patients with COVID-19, with SpO2>93% and with high risk of disease progression including hospitalization or death. Cipla: Press Statement (05 Jan. 2022)

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India. Sun Pharma: Press Release (05 Jan. 2022)

Molnupiravir. U.S. Food & Drug Administration Antimicrobial Drugs Advisory Committee November 30, 2021 (05 Jan. 2022)

EUnetHTA Rolling Collaborative Review (RCR19) Authoring Team. Molnupiravir for the treatment of COVID-19. Diemen (The Netherlands): EUnetHTA; 2020. Report No.: RCR19, v1.0 (05 Jan. 2022)

Molnupiravir (05 Jan. 2022)

European Medicines Agency. Assessment Report: Use of molnupiravir for the treatment of COVID-19 (05 Jan. 2022)

Kabinger F, Stiller C, Schmitzová J, et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat Struct Mol Biol. 2021;28(9):740-746 (05 Jan. 2022)

FDA News Release. Coronavirus (COVID-19) Update: FDA Authorizes Additional Oral Antiviral for Treatment of COVID-19 in Certain Adults. December 23, 2021 (6th Jan. 2022)

Disclaimer

PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.